# Maxcyte, Inc.: Form 8-K, filed Mar 28, 2023

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: 8-K
- Filed: 2023-03-28
- Accepted by EDGAR: Mar 28, 2023, 09:40 ET
- Period: 2023-03-27
- Accession: 0001104659-23-037467
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000110465923037467/tm2310656d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000110465923037467/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000110465923037467/tm2310656d1_8k.htm

Filed Mar 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-037467. Last ingested by Listed: Nov 2, 2026, 10:20 ET. No prices; not investment advice.